Pfizer Appoints New Directors, CAO Departs
Ticker: PFE · Form: 8-K · Filed: Jul 1, 2024 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-election, governance
Related Tickers: PFE
TL;DR
Pfizer's CAO is out, a new interim CAO is in, and two new directors are joining the board.
AI Summary
On June 27, 2024, Pfizer Inc. filed an 8-K report detailing the departure of its Chief Accounting Officer, Michael G. McLellan, effective June 28, 2024. The company also announced the appointment of Sally Susman as Interim Chief Accounting Officer. Additionally, the filing disclosed the election of two new directors, Dr. Roslyn M. Brock and Dr. Robert M. Califf, to its Board of Directors, effective July 1, 2024.
Why It Matters
Changes in key executive positions and board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine executive and board changes, with no immediate financial distress or significant operational disruptions indicated.
Key Players & Entities
- Pfizer Inc. (company) — Registrant
- Michael G. McLellan (person) — Departing Chief Accounting Officer
- Sally Susman (person) — Appointed Interim Chief Accounting Officer
- Dr. Roslyn M. Brock (person) — Elected Director
- Dr. Robert M. Califf (person) — Elected Director
- June 27, 2024 (date) — Date of Report
- June 28, 2024 (date) — Effective Date of CAO Departure
- July 1, 2024 (date) — Effective Date of Director Election
FAQ
Who has been appointed as the interim Chief Accounting Officer at Pfizer?
Sally Susman has been appointed as the interim Chief Accounting Officer.
When was Michael G. McLellan's departure as Chief Accounting Officer effective?
Michael G. McLellan's departure was effective June 28, 2024.
Who are the two new directors elected to Pfizer's Board?
Dr. Roslyn M. Brock and Dr. Robert M. Califf have been elected as new directors.
What is the effective date for the election of the new directors?
The election of the new directors is effective July 1, 2024.
What is the primary purpose of this Form 8-K filing?
This Form 8-K filing reports the departure of a director/officer, election of directors, and compensatory arrangements of certain officers.
Filing Stats: 530 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-07-01 08:07:18
Filing Documents
- pfe-20240627.htm (8-K) — 33KB
- exh99_pressrelease7124.htm (EX-99.1) — 9KB
- pfizerlogoa002.jpg (GRAPHIC) — 38KB
- 0000078003-24-000127.txt ( ) — 251KB
- pfe-20240627.xsd (EX-101.SCH) — 3KB
- pfe-20240627_def.xml (EX-101.DEF) — 15KB
- pfe-20240627_lab.xml (EX-101.LAB) — 27KB
- pfe-20240627_pre.xml (EX-101.PRE) — 16KB
- pfe-20240627_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Exhibit Description Exhibit 99.1 Press Release of Pfizer Inc. dated July 1, 2024 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PFIZER INC. Dated: July 1, 2024 By: /s/ Margaret M. Madden Margaret M. Madden Senior Vice President and Corporate Secretary Chief Governance Counsel